February 25, 2023
Payers and insurers are increasingly implementing restrictive coverage policies, such as limiting patient eligibility criteria, reducing prescription durations from 90 to 30 days, and favoring single-drug formularies to contain escalating costs
This blog post will predict key issues faced by plaintiffs pursuing claims in the ongoing multidistrict litigation against manufacturers of these drugs, and will argue that courts should recognize an exception to the learned intermediary doctrine for GLP-1 RA drugs
Jung, H., Kim, H., Kim, H., Kim, E., Baik, J., & Kang, H
Each batch undergoes extensive quality checks to ensure patient safety and treatment efficacy
But the new program doesnt cover all those treatments, nor the services that can help people achieve and sustain weight loss over the long term